SYDNEY, Australia--(BUSINESS WIRE)--Proteome Systems Ltd (ASX:PXL) today announced the successful closing of a private placement totalling $2.5 million AUD. The Company will issue 23,809,524 shares at A$0.105 per share. Participants in the placement include OppenheimerFunds and other US and Australian investors. Proceeds are being allocated to maintain development timelines for the Company’s two lead diagnostic programmes; a rapid point-of-care test for Tuberculosis and an on-site test for determining wheat quality and thus pricing.
